Failure to effectively prove cause and effect between taking probiotics and improvements in recognised markers of disease has greatly hindered the acceptability of probiotic health claims. • One reason for this may be poor probiotic selection. Probiotic strains have not always been selected on the basis of specific health related mechanisms. • Examples of probiotics first selected for bile salt hydrolase activities or gamma-aminobutyric acid (GABA) production are proving exceptions however, and are showing that rational design of probiotic strains capable of modulating host physiological function is possible. • This presentation will discuss the merits of probiotic reverse engineering, selecting probiotic strains with very specific phenotypes capable altering target mammalian physiological processes.

Tuohy, K.M. (2017). Probiotic reverse engineering: choose your mechanism first then your strain. In: 4th Microbiome R&D and Business collaboration Forum, Amsterdam, April 3-4, 2017. handle: http://hdl.handle.net/10449/46186

Probiotic reverse engineering: choose your mechanism first then your strain

Tuohy, K. M.
2017-01-01

Abstract

Failure to effectively prove cause and effect between taking probiotics and improvements in recognised markers of disease has greatly hindered the acceptability of probiotic health claims. • One reason for this may be poor probiotic selection. Probiotic strains have not always been selected on the basis of specific health related mechanisms. • Examples of probiotics first selected for bile salt hydrolase activities or gamma-aminobutyric acid (GABA) production are proving exceptions however, and are showing that rational design of probiotic strains capable of modulating host physiological function is possible. • This presentation will discuss the merits of probiotic reverse engineering, selecting probiotic strains with very specific phenotypes capable altering target mammalian physiological processes.
Probiotics
Mechanisms
2017
Tuohy, K.M. (2017). Probiotic reverse engineering: choose your mechanism first then your strain. In: 4th Microbiome R&D and Business collaboration Forum, Amsterdam, April 3-4, 2017. handle: http://hdl.handle.net/10449/46186
File in questo prodotto:
File Dimensione Formato  
Amsterdam conference April 3 2017 MRAD17-PBC17_Agenda.pdf

accesso aperto

Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 1.78 MB
Formato Adobe PDF
1.78 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10449/46186
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact